IFNG and myeloid sarcoma: The MS risk variant rs35947132 (p.Ala91Val) is associated with a decrease in target cell-killing efficiency and increases in IFNγ secretion by NK cells (House et al., 2015), which aligns with the aberrant Treg phenotype observed in MS.